β-Catenin in soft tissue sarcomas: Expression is related to proliferative activity in high-grade sarcomas

Modern Pathology

Volumn 13, Issue 9, 2000, Pages 1005-1013

  Kuhnen, Cornelius ^a   Herter, Peter ^b   Müller, Oliver ^b   Muehlberger, Thomas ^a   Krause, Larissa ^a   Homann, Heinz ^a   Steinau, Hans Ulrich ^a   Müller, Klaus Michael ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b MAX PLANCK INSTITUTE OF MOLECULAR PHYSIOLOGY   (Germany)

Author keywords

Immunohistochemistry; Mutation analysis; Soft tissue sarcoma; catenin

Indexed keywords

BETA CATENIN; DNA; MONOCLONAL ANTIBODY; ONCOPROTEIN;

ADULT; AGED; ARTICLE; CANCER GRADING; CELL ADHESION; ELECTRON MICROSCOPY; FEMALE; GENE MUTATION; HUMAN; HUMAN TISSUE; IMMUNOHISTOCHEMISTRY; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROTEIN EXPRESSION; SOFT TISSUE CANCER; SOFT TISSUE SARCOMA;

EID: 0033795924     PISSN: 08933952     EISSN: None     Source Type: Journal    
DOI: 10.1038/modpathol.3880181     Document Type: Article

References (53)

1. The adenomatous polyposis coli (APC) tumor suppressor
2. Regulation of the invasion suppressor function of the cadherin/catenin complex
3. Signal transduction by β-catenin
4. Expression of E-cadherin-associated molecules (α-, β-,γ-catenins and p120) in colorectal polyps
5. β-catenin expression in human cancers
6. Prognostic value of cadherin-associated molecules (α-, β-,γ-catenins and p120(cas)) in bladder tumors
7. Expression of E-cadherin, α-catenin, β-catenin and plakoglobin in esophageal carcinomas and its prognostic significance
8. Embryonic axis induction by the Armadillo repeat domain of β-catenin: Evidence for intracellular signaling
9. Association of the APC tumor suppressor protein with catenins
10. Activation of β-catenin-Tcf signaling in colon cancer by mutations in β-catenin or APC
11. Stabilization of β-catenin by genetic defects in melanoma cell lines
12. Regulation of intracellular β-catenin levels by the adenomatous polyposis coli (APC) tumor-suppressor protein
13. Carcinogenesis. A balance between β-catenin and APC
14. Target genes of β-catenin-T cell-factor/lymphoidenhancer-factor signaling in human colorectal carcinomas
15. β-Catenin regulates expression of cyclin D1 in colon carcinoma cells
16. Functional interaction of β-catenin with the transcription factor LEF-1
17. Nuclear endpoint of Wnt signaling: Neoplasmic transformation induced by transactivating lymphoid-enhancing factor 1
18. β-catenin as oncogene: The smoking gun
19. Growth factor receptor and related oncogene determination in mesenchymal tumors
20. Studies of the retinoblastoma gene in human sarcomas
21. Adenomatous polyposis coli gene mutation alters proliferation through its β-catenin-regulatory function in aggressive fibromatosis (desmoid tumor)
22. Increased β-catenin protein and somatic APC mutations in sporadic aggressive fibromatoses (desmoid tumors)
23. Fibromatosis in the adult
24. Prognostic factors in soft tissue sarcomas
25. Myxofibrosarcoma. Clinicopathologic analysis of 75 cases with emphasis on the low-grade variant
26. Comparative study of the National Cancer Institute and French Federation of Cancer Centers Sarcoma Group grading systems in a population of 410 adult patients with soft tissue sarcoma
27. Immunoenzymatic labeling of monoclonal antibodies using immune complexes of alkaline phosphatase and monoclonal antialkaline phosphatase (APAAP) complexes
28. Prognostic value of Ki-67 expression in 182 soft tissue sarcomas: Proliferation - A marker of metastasis?
29. MIB-1 expression and iododeoxyuridine labelling in soft tissue sarcomas: An immunohistochemical study including correlations with p53, bcl-2 and histological characteristics
30. Proliferative activity (MIB-1 index) is an independent prognostic parameter in patients with high-grade soft tissue sarcomas of subtypes other than malignant fibrous histiocytomas: A retrospective immunohistological study including 216 soft tissue sarcomas
31. Expression of proliferating cell nuclear antigen (PCNA) and Ki-67 in soft tissue sarcoma. Is prognostic significance histotype-specific?
32. A β-catenin mutation in a sporadic colorectal tumor of the RER phenotype and absence of β-catenin germline mutations in FAP patients
33. Intracellular distribution of β-catenin in colorectal adenomas, carcinomas and Peutz-Jeghers polyps
34. Nuclear overexpression of the oncoprotein β-Catenin in colorectal cancer is localized predominantly at the invasion front
35. Hirohashi S-Alteration of β-catenin expression in colonic epithelial cells of familial adenomatous polyposis patients
36. β-catenin expression pattern in stage I and II ovarian carcinomas
37. Tissue-specific expression of β-catenin in normal mesenchyme and uveal melanomas and its effect on invasiveness
38. Dermal fibroblast proliferation is improved by β-catenin overexpression and inhibited by E-cadherin expression
39. Predominance of β-catenin mutations and β-catenin dysregulation in sporadic aggressive fibromatosis (desmoid tumor)
40. β-catenin mutation in carcinoma of the uterine endometrium
41. Somatic mutations of the β-catenin gene are frequent in mouse and human hepatocellular carcinomas
42. β-catenin mutations in human prostate cancer
43. Mutations in the β-catenin gene (CT-NNB1) in endometrioid ovarian carcinomas
44. Sporadic medulloblastomas contain oncogenic β-catenin mutations
45. Frequent nuclear/cytoplasmic localization of β-catenin without exon 3 mutations in malignant melanoma
46. Childhood hepatoblastomas frequently carry a mutated degradation targeting box of the β-catenin gene
47. The expression of β-catenin in non-small-cell lung cancer: A clinico-pathological study
48. Predictive value of nuclear β-catenin expression for the occurrence of distant metastases in rectal cancer